Pharmacologic inhibitors of extracellular signal‐regulated kinase (ERKs) and c‐Jun NH2‐terminal kinase (JNK) decrease glutathione content and sensitize human promonocytic leukemia Cells to arsenic trioxide‐induced apoptosis